Akers Biosciences Further Expands International Distribution of Flagship Rapid Test
April 13, 2015 07:00 ET
|
Akers Biosciences Inc.
THOROFARE, N.J., April 13, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), ("Akers" or the "Company"), a medical device company focused on reducing the cost of healthcare...
Akers Bio Signs Distribution Agreement With ADS for U.S. Govt.
April 02, 2015 07:00 ET
|
Akers Biosciences Inc.
THOROFARE, N.J., April 2, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), ("Akers" or the "Company"), a medical device company focused on reducing the cost of healthcare...
Akers Biosciences Reports Earnings for Fiscal Year 2014
March 23, 2015 07:00 ET
|
Akers Biosciences Inc.
Revenues Up 24% - Flagship PIFA Heparin/PF4 Rapid Test Sales Double
Conference Call Scheduled for 10:30 a.m. ET Today
THOROFARE, N.J., March 23, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc....
Akers Announces Conference Call to Discuss Its Fourth Quarter and Full Year 2014 Earnings
March 19, 2015 07:00 ET
|
Akers Biosciences Inc.
THOROFARE, N.J., March 19, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), ("Akers" or the "Company"), a medical device company focused on reducing the cost of healthcare...
Akers' Management System Certified to ISO 13485 (2003)
February 09, 2015 07:03 ET
|
Akers Biosciences Inc.
THOROFARE, N.J., Feb. 9, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), ("Akers" or the "Company"), a medical device company focused on reducing the cost of healthcare...
Akers Presenting at US Investor Conference
February 05, 2015 13:06 ET
|
Akers Biosciences Inc.
THOROFARE, N.J., Feb. 5, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), ("Akers" or the "Company"), a medical device company focused on reducing the cost of healthcare...
European Patent Granted for Akers' Rapid Blood Separation Technology
January 26, 2015 07:00 ET
|
Akers Biosciences Inc.
THOROFARE, N.J., Jan. 26, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company" or "Akers"), a leading designer and manufacturer of rapid diagnostic screening and...
Akers Expands U.S. Sales Efforts With Key Leadership Additions
January 20, 2015 07:00 ET
|
Akers Biosciences Inc.
THOROFARE, N.J., Jan. 20, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company"), a leading designer and manufacturer of rapid diagnostic screening and testing...
Akers Biosciences Signs European Distribution Agreements for PIFA Heparin PF4 Rapid Assay Products
December 18, 2014 07:00 ET
|
Akers Biosciences Inc.
THOROFARE, N.J., Dec. 18, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company"), a leading designer and manufacturer of rapid diagnostic screening and testing...
Akers Biosciences Announces $1 Million Initial Order to Supply PIFA Heparin/PF4 Products to China
December 10, 2014 07:00 ET
|
Akers Biosciences Inc.
THOROFARE, N.J., Dec. 10, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company"), a leading designer and manufacturer of rapid diagnostic screening and testing...